:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteur principal:	Alison Knopf
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	The Brown University Child & Adolescent Psychopharmacology Update
Accès en ligne:	https://onlinelibrary.wiley.com/doi/10.1002/cpu30922
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

FDA urges higher naloxone doses in fentanyl era
par: Alison Knopf
Publié: (2024)

AAP, HHS warn against expulsions and suspensions
par: Alison Knopf
Publié: (2024)

SAMHSA overdose toolkit contradicts evidence on doses needed
par: Alison Knopf
Publié: (2024)

FDA warns against ultra‐processed food risks to children
Publié: (2025)

Ob‐gyns respond to recent FDA discussion on SSRIs in pregnancy
par: Alison Knopf
Publié: (2025)

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
par: Alison Knopf
Publié: (2026)

HHS critical of “overprescribing” psychiatric medications to children
par: Alison Knopf
Publié: (2026)

Parental substance use and violent behavior by their children
par: Alison Knopf
Publié: (2025)

Temperament in young children associated with specific neuronal networks
par: Alison Knopf
Publié: (2026)

How non‐core autism symptoms in children affect caregivers
par: Alison Knopf
Publié: (2025)

Inflammatory proteins during pregnancy increases risk of disorders in children
par: Alison Knopf
Publié: (2025)

Researchers recommend training ED physicians on suicide risks in children and teens
par: Alison Knopf
Publié: (2024)

Literature review: Melatonin use by young children should be reduced or prevented
par: Alison Knopf
Publié: (2026)

Genes and child rearing both implicated in parental transmission of PTSD and ASRs to children
par: Alison Knopf
Publié: (2024)

Marijuana ingestion in children younger than 5 up more than 1,000%
par: Alison Knopf
Publié: (2025)

FDA requests removal of suicide warnings from two GLP‐1 labels
Publié: (2026)

Researchers call for screening moms for depression before, during, and after pregnancy
par: Alison Knopf
Publié: (2024)

What Chevron doctrine's rejection by Supreme Court could mean for SUD treatment
par: Alison Knopf
Publié: (2024)

Study identifies eight traumatic and ACEs to psychiatric risk across development
par: Alison Knopf
Publié: (2024)

Potential for inflammation biomarkers to identify risk for mental disorders
par: Alison Knopf
Publié: (2024)

Recommendations call for screening before, during, and after pregnancy
par: Alison Knopf
Publié: (2024)

Parent‐guided early intervention for preterm babies improves motor skills
par: Alison Knopf
Publié: (2024)

Rapid initiation protocol for naltrexone for OUD
par: Alison Knopf
Publié: (2024)

Childhood maltreatment causes suicide, depression, and more
par: Alison Knopf
Publié: (2024)

Stress disorders increase in college students
par: Alison Knopf
Publié: (2024)

Final rule for methadone treatment removes barriers for patients under 18
par: Alison Knopf
Publié: (2024)

Rise in child suicide linked to reduced quality of life, parental addiction
par: Alison Knopf
Publié: (2024)

AACAP on advocating amidst stimulant shortage
par: Alison Knopf
Publié: (2024)

Research and clinical use of transcranial magnetic stimulation
par: Alison Knopf
Publié: (2024)

Why a complete medical exam is necessary prior to diagnosing ADHD
par: Alison Knopf
Publié: (2024)

Importance of good sleep in helping prevent subsequent suicidal behaviors
par: Alison Knopf
Publié: (2024)

Why physicians are reluctant to treat addiction
par: Alison Knopf
Publié: (2024)

Experimental, but effective: Noninvasive brain stimulation for various disorders
par: Alison Knopf
Publié: (2024)

CM management, best treatment for stimulant disorder, still on the ropes
par: Alison Knopf
Publié: (2024)

The Cass report, gender identity, and where to go next
par: Alison Knopf
Publié: (2024)

Prescribe for patients with opioid use disorder — with confidence
par: Alison Knopf
Publié: (2024)

ADHD medications with fewer adverse events would improve outcomes
par: Alison Knopf
Publié: (2024)

The rise of the apps: FTC and DOJ crack down on provider selling data
par: Alison Knopf
Publié: (2024)

Confidentiality, clinicians, and parents in mental health care now
par: Alison Knopf
Publié: (2024)

Viloxazine moderate dose associated with good ADHD outcomes
par: Alison Knopf
Publié: (2024)